Vaccine Development Studies

Discover our research on vaccine development

Single-cell Profiling of Biostabilized Natural Human Skin Identifies Mast Cells as an Important Target of Injected mRNA-1273 COVID-19 Vaccine (EMBRN24)

Manon Scholaert1,2, Mathias Peries1, Emilie Braun1, Jeremy Martin2, Nadine Serhan2, Katarzyna Polak1, Alexia Loste2, Audrey Bruner2, Lilian Basso2, Benoit Chaput4, Eric Merle3, Pascal Descargues3, Emeline Pagès1, Nicolas Gaudenzio1,21Genoskin SAS, Toulouse, France – 2Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 – CNRS UMR5051 – University Toulouse III, France – 3Genoskin Inc, Salem MA, USA – 4Department of Plastic, Reconstructive and Aesthetic Surgery, Rangueil Hospital, CHU Toulouse, Toulouse, France.

DOWNLOAD POSTER
Genoskin

Evaluation of Vaccine Potency with High-Dimensional Immune Profiling Using an Innovative Bio-stabilized Human Skin Model (WVC-DC24)

Manon Scholaert1,2, Mathias Peries1, Emilie Braun1, Jeremy Martin2, Nadine Serhan2, Alexia Loste2, Audrey Bruner2, Lilian Basso2, Anna Trevisiol1, Eric Merle3, Emeline Pagès1, Nicolas Gaudenzio1,21Genoskin SAS, Toulouse, France – 2Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 – CNRS UMR5051 – University Toulouse III, France – 3Genoskin Inc, Salem MA, USA

DOWNLOAD POSTER
Genoskin

High-dimensional Profiling of Immune Response to Vaccines Using Biostabilized and Injectable Natural Human Skin (WVC-EU23)

Manon Scholaert1,2, Mathias Peries1, Emilie Braun1, Jeremy Martin2, Nadine Serhan2, Alexia Loste2, Audrey Bruner2, Lilian Basso2, Eric Merle3, Michael Pastore1, Pascal Descargues3, Emeline Pagès1, Nicolas Gaudenzio1,21Genoskin SAS, Toulouse, France – 2Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 – CNRS UMR5051 – University Toulouse III, France – 3Genoskin Inc, Salem MA, USA

DOWNLOAD POSTER

Need more info? Please contact us!